Stay alert, beware of scamsters - know more

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open80.69
High80.69
Low79.27
Prev. Close80.14
Avg. Traded Price79.97
Volume16,266

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
000
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

79.277 hours ago
80.698 hours ago
arrow

LOWER/UPPER CIRCUITS

64.11
96.15
arrow
Anuh Pharma Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 15.66%, in the last year to ₹776.01 Cr. Its sector's average revenue growth for the last fiscal year was 12.14%.
notePrice to Earning Ratio,is 19.57, lower than its sector PE ratio of 44.01.
noteQuarterly Revenue,rose 2.01% YoY to ₹200.86 Cr. Its sector's average revenue growth YoY for the quarter was 12.58%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : 29.44%
Net profit growth 5Y CAGR : 27.05%
Anuh Pharma Ltd Top mutual funds holding
arrow

Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer exporter distributor and manufacturer of bulk drugs chemicals and pharmaceutical formulations.The company's product range includes Macrolides Higher Macrolides Quinolones Chloramphenicol Anti TB Drug & Corticosteroids

personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

The intraday low for Anuh Pharma Ltd on the NSE today was ₹78.68. The stock's 52-week low stands at ₹67.00, recorded on 30 Mar 2026. Today's low is 17.43% above the 52-week low, indicating the stock is trading well above its yearly lows.

For Q4 FY26, Anuh Pharma Ltd reported: Revenue (Net Sales): ₹2021.18 Cr - Up 2.51% year-on-year from ₹1971.78 Cr in Q3 FY26. Net Income (PAT): ₹116.82 Cr - Down -13.16% year-on-year from ₹134.52 Cr in Q3 FY26.

Anuh Pharma Ltd has delivered -21.73% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹107.70 on 21 Jul 2025 and a 52-week low of ₹67.00 on 30 Mar 2026. It is currently trading at ₹80.14 as of 16 Jul 2026.

The all-time high (ATH) for Anuh Pharma Ltd was ₹115.51, recorded on 01 Jan 2025. At the current price of ₹80.14, the stock is trading 30.62% below its all-time high. The all-time low recorded was ₹67.00 on 30 Mar 2026.

As of 16 Jul 2026, the share price of Anuh Pharma Ltd is ₹80.14 on the NSE and ₹79.50 on the BSE. The stock opened at ₹80.69, touched a high of ₹80.87 and a low of ₹78.68 during today's session.

Over the last 6 months, Anuh Pharma Ltd has given a return of 8.46%. The stock was priced at ₹73.88 on 16 Jan 2026 and has Rise to ₹80.14 as of 16 Jul 2026, a change of ₹6.26 per share.

Anuh Pharma Ltd has delivered a N/A% absolute return over the past 5 years, equivalent to a CAGR of N/A% per annum. The stock was priced at ₹N/A in Jul 2021 and has fallen to ₹80.14 as of 16 Jul 2026. An investment of ₹1,00,000 in Anuh Pharma Ltd five years ago would be worth ₹N/A today.

Yes,Anuh Pharma Ltd has declared a consistent dividend every year over the past 5 years. The company paid a total dividend of 9.25 per share between FY2022 and FY2026, with the most recent dividend of ₹1.50 per share for May 26, with an ex-dividend date of 05 Aug 2026. At the current market price of ₹80.14, the trailing dividend yield of Anuh Pharma Ltd stands at 4.00%.

Anuh Pharma Ltd has delivered a return of -3.11% over the last 3 months. The stock was trading at ₹82.70 on 16 Apr 2026 and is currently at ₹80.14 as of 16 Jul 2026, reflecting a Loss of ₹2.56 per share over this period.

The intraday high for Anuh Pharma Ltd on the NSE today (16 Jul 2026) was ₹80.87. This compares to the 52-week high of ₹107.70 recorded on 21 Jul 2025. Today's high was -24.91% below the 52-week high.

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91